Search within:  

Sort results by:      



1-20 of 107   Next >
 
1.  
Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index. 2015 Jun 2. NGC:010722
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Risk reduction of prostate cancer with drugs or nutritional supplements. 2012 May 17. NGC:009863
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
5.  
Lower urinary tract symptoms in men: assessment and management. 2010 May (revised 2015 Jun). NGC:010731
National Clinical Guideline Centre for Acute and Chronic Conditions - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Prostate cancer: diagnosis and treatment. 2008 Feb (revised 2014 Jan). NGC:010205
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
Enzalutamide for metastatic hormone-relapsed prostate cancer previously treated with a docetaxel-containing regimen. 2014 Jul. NGC:010496
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2012 Jul 17). NGC:009101
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)

View associated Guideline Synthesis
9.  
10.  
11.  
Recommendations on screening for prostate cancer with the prostate-specific antigen test. 1994 Jun (revised 2014 Nov 4). NGC:010592
Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12.  
Transrectal ultrasound guided biopsy of the prostate. 2011 Mar. NGC:008543
European Association of Urology Nurses - Medical Specialty Society. View all guidelines by the developer(s)
13.  
14.  
Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer. 2012 Oct 31. NGC:010223
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
15.  
ACR Appropriateness Criteria® post-treatment follow-up of prostate cancer. 1996 (revised 2011). NGC:008453
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
16.  
Guideline for the management of clinically localized prostate cancer: 2007 update. 1995 (revised 2007 Jan; reaffirmed 2011). NGC:005951
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)
17.  
18.  
ACR Appropriateness Criteria® prostate cancer—pretreatment detection, staging and surveillance. 2005 (revised 2012). NGC:009671
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
Early detection of prostate cancer: AUA guideline. 2013 Apr. NGC:009913
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)

View associated Guideline Synthesis
20.  
ACR Appropriateness Criteria® postradical prostatectomy irradiation in prostate cancer. 1996 (revised 2014). NGC:010470
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
1-20 of 107   Next >